Andrew S Huang

Mr. Andrew S Huang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
RVRashmi Venkatesh
Rashmi Venkatesh
AHAndrew S Huang
Andrew S Huang
KGKiya Abdisa Gurmessa
Kiya Abdisa Gurmessa
EHEdbert Hsu
Edbert Hsu
Background: Direct-acting antiviral agents (DAAs) have significantly reduced Hepatitis C Virus (HCV) transmission and improved health outcomes since their FDA approval in 2011. Despite these advances, over 70 million people remain untreated globally, with a disproportionately high burden in low- and middle-income countries (LMICs). Methods: Through a structured search of open access informational sources and an informal peer-reviewed literature review, HCV treatment barriers were identified, compiled, and analyzed. Current challenges to HCV treatment were organized by themes and summarized as recommendations for LMICs. Results: Key obstacles to HCV treatment in LMICs are identified, with the underdiagnosis and undertreatment of the disease linked to inadequate funding and healthcare infrastructure for screening and testing, poor awareness among healthcare providers, and the misinformation and stigmatization of HCV disease. Discussion: Recommendations for LMICs to attenuate treatment obstacles include distributing educational media, implementing mobile clinics, and fostering international partnerships. The successful implementation of these interventions has been demonstrated in developed countries. Conclusions: To achieve the WHO’s goal of eliminating HCV as a public health threat by 2030, concerted efforts are needed by LMICs to reduce gaps in care and ensure that all patients are afforded access to testing and treatment.

27 March 2025 in International Journal of Disaster Studies and Climate Resilience
Verified
Journal Article
Open access
PDF file
FOFunmilayo Oluwatusin
Funmilayo Oluwatusin
AHAndrew S Huang
Andrew S Huang
KGKevin Gianaris
Kevin Gianaris
JAJacob Atem
Jacob Atem
RSRobert Sellke
Robert Sellke
EHEdbert Hsu
Edbert Hsu
The COVID-19 pandemic posed unprecedented challenges worldwide, exacerbating pre-existing vulnerabilities in healthcare systems. As the world’s newest country, South Sudan faced many healthcare barriers that led to distinct challenges in managing the pandemic. After gaining independence in 2011, South Sudan experienced further conflict driven largely by ethnic divisions and competition over resources. The nation was pressed to navigate the pandemic with a healthcare system that has been battered by conflict and inadequate funding. This manuscript assesses emergency management strategies implemented in South Sudan during the COVID-19 pandemic, using publicly available government, private sector, and academic sources. A structured analysis of key components of emergency response—human resources, health service delivery, and logistics—was conducted. Interventions by the Ministry of Health (MOH) included community-based surveillance, updated care guidelines, increased risk communication and community engagement. Despite these, a lack of trust in the government and healthcare system, security challenges, limited resources, and dependence on international aid were identified as notable barriers to the country’s pandemic response. The vaccination campaign in South Sudan was particularly challenging, with only a small percentage of the nation being vaccinated by 2023 despite efforts to increase coverage. While the impact of the strategies implemented cannot be fully appreciated due to limited data, their study can still inform approaches to future public health emergencies.